BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:339@inflames.utu.fi
DTSTART;TZID=Europe/Helsinki:20240425T110000
DTEND;TZID=Europe/Helsinki:20240425T120000
DTSTAMP:20240410T105114Z
URL:https://inflames.utu.fi/events/inflames-guest-seminar-tomas-mustelin-3
 /
SUMMARY:InFLAMES Guest Seminar: Tomas Mustelin (3)
DESCRIPTION:11:00-12:00\, Säätiö-Sali\, Medisiina D\nInFLAMES Guest Semi
 nar:“Lupus pathogenesis: crossing the LINE1?”\nProfessor Tomas Musteli
 n\nDivision Head for Rheumatology\, the University of Washington\n\n&nbsp\
 ;\n\nProfessor Tomas Mustelin\, the Division Head for Rheumatology at the 
 University of Washington\, will visit Turku in the week 17. During his vis
 it he will give three seminars\, all open to everybody.\n\nHe will also be
  available for meetings in the afternoons of his seminar days\, so please 
 reserve a meeting with him using the reservation calendar on the InFLAMES 
 website: https://inflames.utu.fi/contact-us__trashed/reservation-calendars
 /.\n\n&nbsp\;\n\nHis other seminars:\n\nSeminar 1: “Why and how does cit
 rullination occur in rheumatoid arthritis?”\n\nTuesday\, April 23\, Sä
 ätiö-Sali\, Medisiina D\, 11:00–12:00\n\n&nbsp\;\n\nSeminar 2: “The 
 neoantigen hypothesis of autoimmunity.”\n\nTuesday\, April 23\, Sääti
 ö-Sali\, Medisiina D\, 12:00–13:00\n\n&nbsp\;\n\nAbout Professor Mustel
 in:\n\nTomas Mustelin\, MD\, PhD\, professor\, is the Division Head for Rh
 eumatology at University of Washington. He has had a stellar career both i
 n academia and industry. After MD\, PhD at University of Helsinki he pursu
 ed his post-doc at the Scripps Clinic in La Jolla\, California and continu
 ed as PI in the La Jolla Institute for Allergy and Immunology and The Burn
 ham Institute for Medical Research for another 15 years. He then shifted g
 ears\, taking a “brief sabbatical” in Amgen and MedImmune and Gilead. 
 During his over 10 years of industry experience\, he led the discovery of 
 several FDA-approved drugs for autoimmune\, inflammatory/respiratory disea
 ses and immune-oncology.\n\nLinkedIn: https://www.linkedin.com/in/tomas-mu
 stelin-8527a06/
ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/muste
 lin_tomas.jpg
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20240331T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR